News for Athira Pharma, Inc. (ATHA)

Athira Pharma (ATHA) is set to present promising data from a Phase 1 clinical trial of its innovative drug candidate, ATH-1105, during the upcoming 4th Annual A

Net Loss: $96.9 million for the year ended December 31, 2024, compared to $117.7 million in 2023, reflecting a reduction in losses.Earnings Per Share (EPS): Re

Seasoned public company CFO with 25 years of leadership experience in biotech FOSTER CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals,

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND

Aileron Therapeutics, Inc. (ALRN) experienced a notable stock movement with a 6.19% decline in its share price. The shares are now trading at $3.87 with a tradi

Corcept Therapeutics (CORT), a pharmaceutical company specializing in hormone regulation therapies, experienced a significant stock movement with a 5.04% drop i

Shares of Charter Communications, Inc. CHTR rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and rev...

**media[443265]**

Athira Pharma stock plunges to 52-week low of $0.46

Athira Pharma (ATHA) stock plunges 75% as Alzheimer's drug trial fails, leading to downgrades on Wall Street. Read more here.

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.2% on Wednesday. The Dow traded down 0.08% to 40,906.17 while the N...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.1% on Wednesday. The Dow traded up 0.10% to 40,978.50 while the NASDAQ fell 0....

Shares of GitLab Inc. GTLB rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results and issue...

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BOTHELL, Wash., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...

/PRNewswire/ -- The

3 Net-Net Working Capital Stocks, Stocks: ATHA,ABIO,MTCR, release date:Feb 16, 2021

3 Net-Net Working Capital Stocks, Stocks: ATHA,ABIO,MTCR, release date:Feb 16, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders have been taking advantag...